Found: 6
Select item for more details and to access through your institution.
Guselkumab demonstrates long-term efficacy and maintenance of treatment response postwithdrawal in systemic treatment-naïve patients and nonresponders to fumaric acid esters: results from parts II and III of a randomized active-comparator-controlled phase IIIb trial (POLARIS)
- Published in:
- British Journal of Dermatology, 2024, v. 191, n. 1, p. 36, doi. 10.1093/bjd/ljad523
- By:
- Publication type:
- Article
Chronische Entzündungserkrankungen in Deutschland: Eine Querschnittanalyse über Begleiterkrankungen und Arzneimitteleinsatz.
- Published in:
- Zeitschrift für Rheumatologie, 2024, v. 83, n. 3, p. 200, doi. 10.1007/s00393-022-01306-1
- By:
- Publication type:
- Article
Efficacy of Epratuzumab, an Anti‐CD22 Monoclonal IgG Antibody, in Systemic Lupus Erythematosus Patients With Associated Sjögren's Syndrome.
- Published in:
- Arthritis & Rheumatology, 2018, v. 70, n. 5, p. 763, doi. 10.1002/art.40425
- By:
- Publication type:
- Article
PD-L1 expression on tolerogenic APCs is controlled by STAT-3.
- Published in:
- European Journal of Immunology, 2011, v. 41, n. 2, p. 413, doi. 10.1002/eji.201040979
- By:
- Publication type:
- Article
Extractable organic matter of Standard Reference Material 1649a influences immunological response induced by pathogen-associated molecular patterns.
- Published in:
- Environmental Science & Pollution Research, 2010, v. 17, n. 6, p. 1257, doi. 10.1007/s11356-010-0305-3
- By:
- Publication type:
- Article
Airway epithelial cells modify immune responses by inducing an anti-inflammatory microenvironment.
- Published in:
- European Journal of Immunology, 2008, v. 38, n. 6, p. 1689, doi. 10.1002/eji.200737936
- By:
- Publication type:
- Article